Literature DB >> 26386886

Coronary plaque burden regression and high-risk plaque reversal: Potential biomarkers for secondary prevention?

Janet Wei1, Daniel S Berman2, Debiao Li2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26386886      PMCID： PMC4928712          DOI： 10.1016/j.tcm.2015.08.004

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN： 1050-1738            Impact factor:   6.677


× No keyword cloud information.
  19 in total

1.  High-intensity signals in coronary plaques on noncontrast T1-weighted magnetic resonance imaging as a novel determinant of coronary events.

Authors:  Teruo Noguchi; Tomohiro Kawasaki; Atsushi Tanaka; Satoshi Yasuda; Yoichi Goto; Masaharu Ishihara; Kunihiro Nishimura; Yoshihiro Miyamoto; Koichi Node; Nobuhiko Koga
Journal:  J Am Coll Cardiol       Date:  2013-12-15       Impact factor: 24.094

2.  Plaque Characterization by Coronary Computed Tomography Angiography and the Likelihood of Acute Coronary Events in Mid-Term Follow-Up.

Authors:  Sadako Motoyama; Hajime Ito; Masayoshi Sarai; Takeshi Kondo; Hideki Kawai; Yasuomi Nagahara; Hiroto Harigaya; Shino Kan; Hirofumi Anno; Hiroshi Takahashi; Hiroyuki Naruse; Junichi Ishii; Harvey Hecht; Leslee J Shaw; Yukio Ozaki; Jagat Narula
Journal:  J Am Coll Cardiol       Date:  2015-07-28       Impact factor: 24.094

3.  Coronary arterial 18F-FDG uptake by fusion of PET and coronary CT angiography at sites of percutaneous stenting for acute myocardial infarction and stable coronary artery disease.

Authors:  Victor Y Cheng; Piotr J Slomka; Ludovic Le Meunier; Balaji K Tamarappoo; Ryo Nakazato; Damini Dey; Daniel S Berman
Journal:  J Nucl Med       Date:  2012-03-14       Impact factor: 10.057

Review 4.  Regression of coronary atherosclerosis: Current evidence and future perspectives.

Authors:  Konstantinos C Koskinas; Stephan Windecker; Lorenz Räber
Journal:  Trends Cardiovasc Med       Date:  2015-05-19       Impact factor: 6.677

5.  Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.

Authors:  Marc S Sabatine; Robert P Giugliano; Stephen D Wiviott; Frederick J Raal; Dirk J Blom; Jennifer Robinson; Christie M Ballantyne; Ransi Somaratne; Jason Legg; Scott M Wasserman; Robert Scott; Michael J Koren; Evan A Stein
Journal:  N Engl J Med       Date:  2015-03-15       Impact factor: 91.245

6.  Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.

Authors:  Jennifer G Robinson; Michel Farnier; Michel Krempf; Jean Bergeron; Gérald Luc; Maurizio Averna; Erik S Stroes; Gisle Langslet; Frederick J Raal; Mahfouz El Shahawy; Michael J Koren; Norman E Lepor; Christelle Lorenzato; Robert Pordy; Umesh Chaudhari; John J P Kastelein
Journal:  N Engl J Med       Date:  2015-03-15       Impact factor: 91.245

7.  Interscan reproducibility of quantitative coronary plaque volume and composition from CT coronary angiography using an automated method.

Authors:  Annika Schuhbaeck; Damini Dey; Yuka Otaki; Piotr Slomka; Brian G Kral; Stephan Achenbach; Daniel S Berman; Elliott K Fishman; Shenghan Lai; Hong Lai
Journal:  Eur Radiol       Date:  2014-06-25       Impact factor: 5.315

8.  Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis.

Authors:  Brendan M Everett; Aruna D Pradhan; Daniel H Solomon; Nina Paynter; Jean Macfadyen; Elaine Zaharris; Milan Gupta; Michael Clearfield; Peter Libby; Ahmed A K Hasan; Robert J Glynn; Paul M Ridker
Journal:  Am Heart J       Date:  2013-05-03       Impact factor: 4.749

Review 9.  Contrast-enhanced cardiovascular magnetic resonance imaging of coronary vessel wall: state of art.

Authors:  Yen-Shu Kuo; Sebastian Kelle; Charlotte Lee; Rocio Hinojar; Eike Nagel; Rene Botnar; Valentina O Puntmann
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-01-13

10.  18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.

Authors:  Nikhil V Joshi; Alex T Vesey; Michelle C Williams; Anoop S V Shah; Patrick A Calvert; Felicity H M Craighead; Su Ern Yeoh; William Wallace; Donald Salter; Alison M Fletcher; Edwin J R van Beek; Andrew D Flapan; Neal G Uren; Miles W H Behan; Nicholas L M Cruden; Nicholas L Mills; Keith A A Fox; James H F Rudd; Marc R Dweck; David E Newby
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.